Rapid dose escalation of quetiapine versus conventional escalation in the treatment of patients with acute schizophrenia - multicentre, double-blind, parallel group, randomized study.

Trial Profile

Rapid dose escalation of quetiapine versus conventional escalation in the treatment of patients with acute schizophrenia - multicentre, double-blind, parallel group, randomized study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2011

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Schizophrenia
  • Focus Adverse reactions
  • Acronyms RACE
  • Sponsors AstraZeneca
  • Most Recent Events

    • 01 Apr 2009 Actual end date (Jan 2006) added as reported by ClinicalTrials.gov.
    • 30 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top